Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Researchers discover that anti-malaria drugs can fight pulmonary disease

A research team at Colorado State University has discovered that drugs used to treat malaria are also effective at treating a pulmonary disease similar to tuberculosis. Their findings were featured on the cover of the Feb. 23 issue of Science Translational Medicine. The study is a significant development in the fight against infections caused by […]

Do ‘behavioral psychedelics’ help patients make lasting, positive change?

Despite their reputation as illicit drugs, psychedelics may find new, legitimate roles in treatment for anxiety, depression, stress disorders, addiction, and other mental and behavioral health problems. But ensuring they do requires developing rigorous, standardized methods to study and apply the results, according to a new report. In a perspective published in Frontiers in Psychiatry, […]

New target may help protect bones as we age

Drugs we take like prednisone can weaken our bones and so can aging, and scientists working to prevent both have some of the first evidence that the best target may not be the logical one. They are finding that in aging bone, the mineralocorticoid receptor, better known for its role in blood pressure regulation, is […]

Diet trumps drugs for anti-aging and good metabolic health

A study comparing the impact of diet versus drugs on the inner workings of our cells has found nutrition has a much stronger impact. The pre-clinical study by the University of Sydney’s Charles Perkins Centre suggests the makeup of our diet could be more powerful than drugs in keeping conditions like diabetes, stroke and heart […]

Different Taxanes, Similar Outcomes in Advanced HER2-Positive Breast Cancer

Final results from a routine-practice comparison of taxane agents showed that the drugs offered comparable safety and efficacy in advanced HER2-positive breast cancer. Median progression-free survival (PFS) was about 21 months and median overall survival (OS) was 65 months with dual anti-HER2 therapy and was similar among patients who received paclitaxel or docetaxel, as well […]

Fuzzy OS Benefits in Drug Labels; Zantac Suit Dismissed; Cancer Deaths Drop For Now

The overall survival benefits associated with use of many newly approved cancer drugs are often not clearly communicated in drug labels. (JAMA Internal Medicine) A reduced-dose CT scan of 0.3 mSv can safely be used to detect lung nodules in children with cancer without sacrificing diagnostic accuracy. (American Journal of Roentgenology) A federal judge has […]

DBN Health News